0 CHECKOUT

European Securitization Market Weathers Global Economic Downturn in First Quarter 2001 Apr 01

  • ID: 1817604
  • April 2001
  • Region: Global, Europe
  • Standard & Poors
1 of 3

FEATURED COMPANIES

  • Bank of Scotland PLC
  • Ireland (Republic of)
  • Japan
  • NRAM PLC
  • Spain (Kingdom of)
  • Swiss Confederation
  • MORE

Abstract
Despite the global economic downturn of recent months triggered by plunging stock markets and flagging Japanese and U.S. economies, the European securitization market has weathered the volatile climate, with volumes ending a hefty 60% higher at $29.9 billion compared with $18.7 billion in the same quarter of 2000. Kurt Sampson, managing director at Standard & Poor's Structured Finance Ratings group in London said this strong first quarter performance puts the European asset-backed market well en route to achieving at least a 20% year-end growth target. "It's been an impressive first quarter and the depth of the pipeline for the coming months should see us reach the year's end at least 20% higher," he said. "Investor appetite also remains strong, which...

Companies mentioned in this report are:
- Sweden (Kingdom of)
- Bank of Scotland PLC
- France (Republic of)
- Japan
- United Kingdom
- Spain (Kingdom of)
- Germany (Federal Republic of)
- Italy (Republic of)
- Swiss Confederation
- Ireland (Republic of)
- Netherlands (State of The)
- Portugal (Republic of)
- Turkey (Republic of)
- NRAM PLC
- Multicanal S.A.
- Rheinische READ MORE >

Note: Product cover images may vary from those shown
2 of 3

- Sweden (Kingdom of)
- Bank of Scotland PLC
- France (Republic of)
- Japan
- United Kingdom
- Spain (Kingdom of)
- Germany (Federal Republic of)
- Italy (Republic of)
- Swiss Confederation
- Ireland (Republic of)
- Netherlands (State of The)
- Portugal (Republic of)
- Turkey (Republic of)
- NRAM PLC
- Multicanal S.A.
- Rheinische Hypothekenbank AG
- Equity Release Funding (No.1) PLC

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.